#4: Who are the CDMOs? For whom is their capacity being deployed to produce COVID vaccines?

by Öner Tulum, William Lazonick, and Ken Jacobson In responding to the COVID-19 pandemic, the global pharmaceutical industry has done something unprecedented: In less than one year, it has developed several vaccines and obtained regulatory approval for some of them….

#2: How effectively is global capacity being utilized? Is there any idle capacity to press into service?

by Öner Tulum, William Lazonick, and Ken Jacobson                           Despite vaccines’ significant public-health benefits, sales of all vaccines accounted for less than four percent of $872 billion in prescription-drug…

#1: Is there enough production capacity available for the vaccine supply to meet urgent demand in 2021?

by Öner Tulum, William Lazonick, and Ken Jacobson                           As COVID-19 vaccines receive regulatory approval, the world has a powerful weapon to fight the coronavirus. But at what pace…